Premium
Intravenous immunoglobulins in dermatology. Part 2: clinical indications and outcomes
Author(s) -
Forbat E.,
Ali F. R.,
AlNiaimi F.
Publication year - 2018
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/ced.13552
Subject(s) - medicine , intravenous immunoglobulins , randomized controlled trial , dermatology , antibody , clinical trial , immunoglobulin e , intensive care medicine , immunology , surgery
Summary Intravenous immunoglobulin ( IVI g) is a solution of human IgG, salt, sugars and solvents used to treat a multitude of diseases. Although IVI g has been known to treat many diseases safely and successfully, there are relatively few supporting randomized controlled trials. In part two of this review, we assess the clinical indications of IVI g in dermatological disorders and the outcomes of its use.